The U.S. healthcare data monetization market size was estimated at USD 137.9 million in 2025 and is predicted to increase from USD 158.92 million in 2026 to approximately USD 569.64 million by 2035, expanding at a CAGR of 15.24% from 2026 to 2035 Rising demand for real-world data from pharma & biotech firms, coupled with an emphasis on AI-powered data platforms, is driving the market expansion.
The U.S. healthcare data monetization market covers the extraction of value from patient records, claims, & wearable data to propel revenue & research. This mainly focuses on Real-World Data (RWD) to enhance patient care, speed up drug development, & improving healthcare operations. The U.S. companies have greater applications in collecting & licensing de-identified patient data to pharmaceutical & biotech leaders. Alongside, the market pushes diverse, advanced analytics-enabled platforms that enable stakeholders to evaluate population health trends, enhance billing, & raise supply chain effectiveness.
Eventually, the U.S. healthcare data monetization market will increasingly explore integration of machine learning & NLP that enable vast amounts of unstructured medical data to be rapidly processed & sold via protected health data market networks. Moreover, novelty features federated learning & blockchain technology, which allow firms to monetize algorithms trained on clinical data without providing the underlying sensitive patient information.
Diverse healthcare providers across the U.S. healthcare data monetization market are leveraging data analytics to simplify operations, including optimizing surgical scheduling and lowering supply chain challenges. This further enhances resource allocation, which majorly fuels down administrative & clinical spending. Across the U.S., these healthcare providers are focusing on the development of cloud-native data platforms & population health analytics, especially for health systems.
By data type, the clinical data segment dominated with a 32% share of the U.S. healthcare data monetization market in 2025. Dominance is driven by rigorous healthcare systems fostering EHR interoperability initiatives across hospitals & clinics. Whereas pharmaceutical companies increasingly acquire longitudinal patient datasets for R&D, AI-based diagnostic model training continues to increase demand for structured clinical records.
By monetization model, the direct data licensing segment led with a 28% share of the market in 2025. Many healthcare organizations are licensing de-identified datasets to life sciences players. However, regulatory clarity supports the wider commercialization of healthcare information assets. The growing demand for structured clinical datasets continues to increase among research institutions.
By end user, the healthcare providers segment held a dominant share of 31% of the U.S. healthcare data monetization market in 2025. Primarily, hospitals generate extensive patient & operational datasets for commercialization, driving the demand for the latest approaches. Moreover, integrated delivery networks expand partnerships with analytics companies. Numerous providers monetize de-identified clinical records for research initiatives.
By application, the clinical research & trial optimization segment led with a 26% share of the market in 2025. Many pharmaceutical leaders are increasingly leveraging healthcare datasets for patient recruitment. Whereas decentralized trials require real-world evidence integration capabilities. Developing AI-powered analytics accelerates clinical development timelines.
By data source, the electronic health records systems segment captured a dominant share of 34% of the U.S. healthcare data monetization market in 2025. Broader adoption of EHR across the U.S. is evolving comprehensive, structured patient datasets, which fuel the respective dominance. Moreover, interoperability mandates improve accessibility across healthcare ecosystems, while AI vendors increasingly rely on EHR datasets for model training.
Oracle Corporation, Microsoft Corporation, IQVIA, & Optum (UnitedHealth Group) are four major companies in the U.S. that are spurring real-time data analytics & cloud data management systems across clinical trials. From these four, Oracle Corporation is dominating its position in the market by rolling out the Oracle Health Data Intelligence (formerly Oracle Health Sciences Data Warehouse).
By Data Type
By Monetization Model
By Deployment Mode
By Organization Size
By End User
By Application
By Data Source
By Technology
